fig1
From: EGFR signaling promotes resistance to CHK1 inhibitor prexasertib in triple negative breast cancer
Figure 1. Sensitivity of TNBC cell lines to CHK1 inhibitor prexasertib. IC50 values are expressed as mean ± standard error of the mean (SEM). TNBC: triple negative breast cancer
